P1275: PERCENTAGE OF TUMOR INFILTRATING T LYMPHOCYTES MEASURED BY FLOW CYTOMETRY AT DIAGNOSIS PREDICTS SURVIVAL AFTER SALVAGE CHEMOTHERAPY IN RELAPSED/ REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA PATIENTS.

Detalles Bibliográficos
Autores principales: Korin, L., Fuente, M., Cranco, S., Vitriu, A., Ochoa, P., Babuin, E., Gelo, O., Ayala, L., Tempra, P., Venegas, M., Novoa, A., Vijnovich, A., Tartas, N., Custidiano, M. D. R., Foncuberta, M. C., Sanchez Avalos, J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Posters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429470/
http://dx.doi.org/10.1097/01.HS9.0000847964.45968.60
_version_ 1784779454240784384
author Korin, L.
Fuente, M.
Cranco, S.
Vitriu, A.
Ochoa, P.
Babuin, E.
Gelo, O.
Ayala, L.
Tempra, P.
Venegas, M.
Novoa, A.
Vijnovich, A.
Tartas, N.
Custidiano, M. D. R.
Foncuberta, M. C.
Sanchez Avalos, J.
author_facet Korin, L.
Fuente, M.
Cranco, S.
Vitriu, A.
Ochoa, P.
Babuin, E.
Gelo, O.
Ayala, L.
Tempra, P.
Venegas, M.
Novoa, A.
Vijnovich, A.
Tartas, N.
Custidiano, M. D. R.
Foncuberta, M. C.
Sanchez Avalos, J.
author_sort Korin, L.
collection PubMed
description
format Online
Article
Text
id pubmed-9429470
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-94294702022-08-31 P1275: PERCENTAGE OF TUMOR INFILTRATING T LYMPHOCYTES MEASURED BY FLOW CYTOMETRY AT DIAGNOSIS PREDICTS SURVIVAL AFTER SALVAGE CHEMOTHERAPY IN RELAPSED/ REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA PATIENTS. Korin, L. Fuente, M. Cranco, S. Vitriu, A. Ochoa, P. Babuin, E. Gelo, O. Ayala, L. Tempra, P. Venegas, M. Novoa, A. Vijnovich, A. Tartas, N. Custidiano, M. D. R. Foncuberta, M. C. Sanchez Avalos, J. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9429470/ http://dx.doi.org/10.1097/01.HS9.0000847964.45968.60 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Korin, L.
Fuente, M.
Cranco, S.
Vitriu, A.
Ochoa, P.
Babuin, E.
Gelo, O.
Ayala, L.
Tempra, P.
Venegas, M.
Novoa, A.
Vijnovich, A.
Tartas, N.
Custidiano, M. D. R.
Foncuberta, M. C.
Sanchez Avalos, J.
P1275: PERCENTAGE OF TUMOR INFILTRATING T LYMPHOCYTES MEASURED BY FLOW CYTOMETRY AT DIAGNOSIS PREDICTS SURVIVAL AFTER SALVAGE CHEMOTHERAPY IN RELAPSED/ REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA PATIENTS.
title P1275: PERCENTAGE OF TUMOR INFILTRATING T LYMPHOCYTES MEASURED BY FLOW CYTOMETRY AT DIAGNOSIS PREDICTS SURVIVAL AFTER SALVAGE CHEMOTHERAPY IN RELAPSED/ REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA PATIENTS.
title_full P1275: PERCENTAGE OF TUMOR INFILTRATING T LYMPHOCYTES MEASURED BY FLOW CYTOMETRY AT DIAGNOSIS PREDICTS SURVIVAL AFTER SALVAGE CHEMOTHERAPY IN RELAPSED/ REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA PATIENTS.
title_fullStr P1275: PERCENTAGE OF TUMOR INFILTRATING T LYMPHOCYTES MEASURED BY FLOW CYTOMETRY AT DIAGNOSIS PREDICTS SURVIVAL AFTER SALVAGE CHEMOTHERAPY IN RELAPSED/ REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA PATIENTS.
title_full_unstemmed P1275: PERCENTAGE OF TUMOR INFILTRATING T LYMPHOCYTES MEASURED BY FLOW CYTOMETRY AT DIAGNOSIS PREDICTS SURVIVAL AFTER SALVAGE CHEMOTHERAPY IN RELAPSED/ REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA PATIENTS.
title_short P1275: PERCENTAGE OF TUMOR INFILTRATING T LYMPHOCYTES MEASURED BY FLOW CYTOMETRY AT DIAGNOSIS PREDICTS SURVIVAL AFTER SALVAGE CHEMOTHERAPY IN RELAPSED/ REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA PATIENTS.
title_sort p1275: percentage of tumor infiltrating t lymphocytes measured by flow cytometry at diagnosis predicts survival after salvage chemotherapy in relapsed/ refractory diffuse large b cell lymphoma patients.
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429470/
http://dx.doi.org/10.1097/01.HS9.0000847964.45968.60
work_keys_str_mv AT korinl p1275percentageoftumorinfiltratingtlymphocytesmeasuredbyflowcytometryatdiagnosispredictssurvivalaftersalvagechemotherapyinrelapsedrefractorydiffuselargebcelllymphomapatients
AT fuentem p1275percentageoftumorinfiltratingtlymphocytesmeasuredbyflowcytometryatdiagnosispredictssurvivalaftersalvagechemotherapyinrelapsedrefractorydiffuselargebcelllymphomapatients
AT crancos p1275percentageoftumorinfiltratingtlymphocytesmeasuredbyflowcytometryatdiagnosispredictssurvivalaftersalvagechemotherapyinrelapsedrefractorydiffuselargebcelllymphomapatients
AT vitriua p1275percentageoftumorinfiltratingtlymphocytesmeasuredbyflowcytometryatdiagnosispredictssurvivalaftersalvagechemotherapyinrelapsedrefractorydiffuselargebcelllymphomapatients
AT ochoap p1275percentageoftumorinfiltratingtlymphocytesmeasuredbyflowcytometryatdiagnosispredictssurvivalaftersalvagechemotherapyinrelapsedrefractorydiffuselargebcelllymphomapatients
AT babuine p1275percentageoftumorinfiltratingtlymphocytesmeasuredbyflowcytometryatdiagnosispredictssurvivalaftersalvagechemotherapyinrelapsedrefractorydiffuselargebcelllymphomapatients
AT geloo p1275percentageoftumorinfiltratingtlymphocytesmeasuredbyflowcytometryatdiagnosispredictssurvivalaftersalvagechemotherapyinrelapsedrefractorydiffuselargebcelllymphomapatients
AT ayalal p1275percentageoftumorinfiltratingtlymphocytesmeasuredbyflowcytometryatdiagnosispredictssurvivalaftersalvagechemotherapyinrelapsedrefractorydiffuselargebcelllymphomapatients
AT temprap p1275percentageoftumorinfiltratingtlymphocytesmeasuredbyflowcytometryatdiagnosispredictssurvivalaftersalvagechemotherapyinrelapsedrefractorydiffuselargebcelllymphomapatients
AT venegasm p1275percentageoftumorinfiltratingtlymphocytesmeasuredbyflowcytometryatdiagnosispredictssurvivalaftersalvagechemotherapyinrelapsedrefractorydiffuselargebcelllymphomapatients
AT novoaa p1275percentageoftumorinfiltratingtlymphocytesmeasuredbyflowcytometryatdiagnosispredictssurvivalaftersalvagechemotherapyinrelapsedrefractorydiffuselargebcelllymphomapatients
AT vijnovicha p1275percentageoftumorinfiltratingtlymphocytesmeasuredbyflowcytometryatdiagnosispredictssurvivalaftersalvagechemotherapyinrelapsedrefractorydiffuselargebcelllymphomapatients
AT tartasn p1275percentageoftumorinfiltratingtlymphocytesmeasuredbyflowcytometryatdiagnosispredictssurvivalaftersalvagechemotherapyinrelapsedrefractorydiffuselargebcelllymphomapatients
AT custidianomdr p1275percentageoftumorinfiltratingtlymphocytesmeasuredbyflowcytometryatdiagnosispredictssurvivalaftersalvagechemotherapyinrelapsedrefractorydiffuselargebcelllymphomapatients
AT foncubertamc p1275percentageoftumorinfiltratingtlymphocytesmeasuredbyflowcytometryatdiagnosispredictssurvivalaftersalvagechemotherapyinrelapsedrefractorydiffuselargebcelllymphomapatients
AT sanchezavalosj p1275percentageoftumorinfiltratingtlymphocytesmeasuredbyflowcytometryatdiagnosispredictssurvivalaftersalvagechemotherapyinrelapsedrefractorydiffuselargebcelllymphomapatients

Ejemplares similares